Genmab AS Stock Performance
as on May 15, 2026 at 2:15 pm IST
Day's Low
Day's High
$26.18$27.17
2.68%
Downside
1.00%
Upside
52 Week's Low
52 Week's High
$19.32$35.4328.18%
Downside
31.71%
Upside
Genmab AS share price movements today
- Previous Close
- $26.55
- Open
- $26.55
- Volume
- 1.5M
- Day's Low - High
- $26.18 - $27.17
- 52 Week Low - High
- $19.32 - $35.43
Genmab AS Historical Returns
- 1 Month Return
- -8.19 %
- 3 Month Return
- -10.42 %
- 1 Year Return
- + 36.9 %
- 3 Year Return
- -36.17 %
- 5 Year Return
- -27.45 %
Genmab AS Stock Fundamentals & Key Indicators
Check Genmab AS market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$16.3B
EPS (TTM)
1.0921
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.73%
PE Ratio (TTM)
20.27
Industry PE ratio
-5.1839130434782605
PEG Ratio
1.6808
EBITDA
1.3B
Revenue (TTM)
3.9B
Profit Margin
21.05%
Return On Equity TTM
14.96%
Genmab AS Stock Valuation
Track how Genmab AS P/E has moved over time to understand its valuation trends.
Genmab AS in the last 5 years
Lowest (10.37x)
June 30, 2025
Industry (-5.18x)
May 15, 2026
Today (20.27x)
May 15, 2026
Highest (64.13x)
September 30, 2021
Today’s Price to Earnings Ratio: 20.27x
Genmab AS vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Genmab AS with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $16.3B | -27.45% | 20.27 | 21.05% | |
| BUY | $38.9B | 116.25% | 73.05 | 12.55% | |
| NA | $31.6B | NA | 68.92 | 8.94% | |
| BUY | $115.0B | 107.48% | 26.89 | 35.51% | |
| BUY | $75.5B | 37.99% | 17.58 | 29.65% |
Stock Returns calculator for Genmab AS Stock including INR - Dollar returns
The Genmab AS stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Genmab AS investment value today
Current value as on today
₹1,53,500
Returns
₹53,500
(+53.5%)
Returns from Genmab AS Stock
₹36,896 (+36.9%)
Dollar Impact
₹16,605 (+16.6%)
Analyst Recommendation on Genmab AS Stock
Based on 31 analysts
61.29%
Buy
29.03%
Hold
9.68%
Sell
Based on 31 analysts, 61.29% of analysts recommend a 'BUY' rating for Genmab AS. Average target price of $37.55
Genmab AS Share Price Target
Get share price movements and forecasts by analysts on Genmab AS.
What analysts predicted
28.36%UPSIDE
Target Price
$37.55
Current Price
$26.9
Analyzed by
31 Analysts
Target
$37.55
Genmab AS target price $37.55, a slight upside of 28.36% compared to current price of $26.9. According to 31 analysts rating.
Indian Investors' Interest in Genmab AS Stock
Search interest for Genmab AS Stock has increased by 45% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:45% versus previous 30 day period
Genmab AS Quarterly Profit & Loss
All numbers in Millions USD
Genmab AS Annual Profit & Loss
All numbers in Millions USD
Genmab AS Quarterly Cash Flow
All numbers in Millions USD
Genmab AS Annual Cash Flow
All numbers in Millions USD
Genmab AS News & Key Events
Today's Timeline - 07 May
Thu, 08:32 PM
-Genmab reports Q1 2026 revenue growth of 25% to $896 million, driven by higher product sales and royalties.
Thu, 08:36 PM
-Genmab's operating profit misses expectations at $180 million, below the anticipated $187 million.
Fri, 02:28 AM
-Genmab maintains 2026 guidance with 14% revenue growth outlook, driven by EPKINLY and royalty portfolio.
Insights on Genmab AS
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 2 quarters, 30.90M → 53.19M (in $), with an average increase of 41.9% per quarter
NO EFFECTAgainst Peers
In the last 1 year, BeOne Medicines Ltd has given 40.2% return, outperforming this stock by 5.1%
- NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 31.8% return, outperforming this stock by 68.8%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 1.05B → 899.31M (in $), with an average decrease of 14.7% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, GMAB stock has moved down by -9.4%
About Genmab AS
| Organisation | Genmab AS |
| Headquarters | Carl Jacobsens Vej 30, Copenhagen, Denmark, 2500 |
| Industry | Biotechnology |
| CEO | Dr. Jan G.J. van de Winkel Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Genmab AS
Name | Title |
|---|---|
Mr. Gregory David Emil Mueller | Executive VP, General Counsel & Chief Legal Officer |
Mr. Christopher Cozic | Executive VP & Chief People Officer |
Dr. Judith V. Klimovsky M.D. | Executive VP & Chief Development Officer |
Dr. Mijke Zachariasse Ph.D. | VP, Head of Antibody Research Materials & Director |
Dr. Jan G.J. van de Winkel Ph.D. | Co-Founder, President & CEO |
Mr. Anthony Pagano CPA | Executive VP & CFO |
Mr. Rayne Waller | Executive VP & Chief Technical Operations Officer |
Dr. Martine J. van Vugt Ph.D. | Executive VP & Chief Strategy Officer |
Mr. Martin Schultz | Senior Director, Head of Development Business Partnership & Strategy and Director |
Dr. Tahamtan Ahmadi M.D., Ph.D. | Executive VP, Chief Medical Officer & Head of Experimental Medicines |
FAQs
What is Genmab AS share price today?
Genmab AS share price today is $26.9 as on at the close of the market. Genmab AS share today touched a day high of $27.17 and a low of $26.18.
What is the 52 week high and 52 week low for Genmab AS share?
Genmab AS share touched a 52 week high of $35.43 on and a 52 week low of $19.32 on . Genmab AS stock price today i.e. is closed at $26.9,which is 24.08% down from its 52 week high and 39.23% up from its 52 week low.
What is Genmab AS's market capitalisation today?
Genmab AS market capitalisation is $0.02T as on .
How to invest in Genmab AS Stock (GMAB) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Genmab AS on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Genmab AS Shares that will get you 0.0558 shares as per Genmab AS share price of $26.9 per share as on May 15, 2026 at 8:45 am IST.
What is the minimum amount required to buy Genmab AS Stock (GMAB) from India?
Indian investors can start investing in Genmab AS (GMAB) shares with as little as ₹95.753 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.53 in Genmab AS stock (as per the Rupee-Dollar exchange rate as on ).
Based on Genmab AS share’s latest price of $26.9 as on May 15, 2026 at 8:45 am IST, you will get 0.3717 shares of Genmab AS. Learn more about
fractional shares .
What are the returns that Genmab AS has given to Indian investors in the last 5 years?
Genmab AS stock has given -27.45% share price returns and 30.03% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?